insights_auto
Why is MBIO up 4,90%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
US$0,43
arrow_upward
+4,90%(+0,020) 1D
9 ຕ.ລ., 12 ໂມງ 31 ນາທີ 50 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,24 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
77,64 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,24 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
77,64 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
News stories
From web sources and news partners
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
www.marketscreener.com
·
11 ນາທີກ່ອນ
TRex Bio Shares Trade Lower in Nasdaq Debut
MarketBeat
·
26 ນາທີກ່ອນ
Latigo Biotherapeutics (NASDAQ:LTGO) Shares Climb 6.2% - Time to Buy?
Nasdaq
·
3 ຊົ່ວໂມງກ່ອນ
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitemustangbio.com